scyllo-Inositol Promotes Robust Mutant Huntingtin Protein Degradation
Authors:
Open Access
- 1 February 2014
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (6) , 3666-3676
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Protein aggregates in Huntington's diseaseExperimental Neurology, 2012
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 2012
- Identifying polyglutamine protein species in situ that best predict neurodegenerationNature Chemical Biology, 2011
- The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activityCell Death & Disease, 2011
- Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 MutationsCell, 2010
- Prion-like transmission of protein aggregates in neurodegenerative diseasesNature Reviews Molecular Cell Biology, 2010
- Huntington disease models and human neuropathology: similarities and differencesActa Neuropathologica, 2007
- A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouseProceedings of the National Academy of Sciences, 2007
- Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse modelNature Medicine, 2006
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004